| Bioactivity | L319 is an ionizable cationic lipidoid and can be used for synthetic liposomes, from the patent WO-2011153493-A2, compound 1[1]. | ||||||||||||
| Invitro | L319 (Di((Z)-Non-2-en-1-yl) 9-((4-(dimethylamino)butanoyl)oxy)heptadecanedioate) can be used for synthetic liposomes[1]. | ||||||||||||
| Name | L319 | ||||||||||||
| CAS | 1351586-50-9 | ||||||||||||
| Formula | C41H75NO6 | ||||||||||||
| Molar Mass | 678.04 | ||||||||||||
| Appearance | Liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Biodegradable lipids for the delivery of active agents. WO2011153493A2 [2]. Maier MA, Jayaraman M, Matsuda S, et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol Ther. 2013;21(8):1570-1578. |